🇺🇸 FDA
Patent

US 6713478

Cyclocarbamate derivatives as progesterone receptor modulators

expired A61PA61P15/00A61P15/18

Quick answer

US patent 6713478 (Cyclocarbamate derivatives as progesterone receptor modulators) held by Ligand Pharmaceuticals Incorporated expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
49
CPC classes
A61P, A61P15/00, A61P15/18, A61P35/00, A61P43/00